cargo-tx.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $507.54MM
Cargo Therapeutics is a biotechnology company that specializes in developing precision therapeutics for cancer treatment. Their proprietary technology platform enables the targeted delivery of small molecules and biologics to cancer cells, while minimizing off-target effects on healthy cells. The company's lead product candidate, CT-100, is a novel therapeutic that selectively targets cancer cells expressing the protein EphA2, which is overexpressed in a variety of solid tumors. Cargo Therapeutics aims to improve patient outcomes and reduce the toxicity of cancer treatments with their precision therapeutics.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/31/2023 | Series A-1 | $86.04MM | $xx.xx | $302.29MM | Ally Bridge Group, Cormorant, Cormorant Capital, Emerson Collective, Janus Henderson, Nextech, Piper Heartland, Piper Sandler, Red Tree Venture, Rtw Investments, Rtw Sandler, Samsara Biocapital, Third Rock Ventures, T. Rowe Price, Wellington, Xontongey | |
Price per Share
$xx.xx
Shares Outstanding
6,341,148
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ally Bridge Group, Cormorant, Cormorant Capital, Emerson Collective, Janus Henderson, Nextech, Piper Heartland, Piper Sandler, Red Tree Venture, Rtw Investments, Rtw Sandler, Samsara Biocapital, Third Rock Ventures, T. Rowe Price, Wellington, Xontongey
|
||||||
12/09/2022 | Series A-2 | $34.42MM | $xx.xx | $68.53MM | Emerson Collective, Janus Henderson, Red Tree Venture Capital, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
3,381,941
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Emerson Collective, Janus Henderson, Red Tree Venture Capital, Samsara Biocapital
|
||||||
04/26/2022 | Series Seed | $11MM | $xx.xx | $24.44MM | Emerson Collective, Red Tree Venture, Samsara Biocapital | |
Price per Share
$xx.xx
Shares Outstanding
810,700
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Emerson Collective, Red Tree Venture, Samsara Biocapital
|